Chief Executive Officer, Tally Health

Melanie Goldey is a dynamic executive with deep experience driving strategic and operational excellence and building world-class teams at technology-enabled, high-growth, public and private companies through periods of scale and transformation. Melanie is the Chief Executive Officer of Tally Health, a biotech company developing science-backed tools and resources to help consumers increase healthspan, extend longevity, and age healthier. Prior to Tally, she was COO & CFO of TMRW Life Sciences, a life sciences tech company providing an automated, software-guided specimen management solution for the egg and embryos used in IVF. Previously, Melanie served as CFO of Refinery29, where she led its merger with Vice Media Group, and as SVP of Everyday Health Group, where she helped scale the company through its IPO and subsequent acquisition. She began her career as a technology and media investment banker at J.P. Morgan. Melanie is a member of the Fast Company Impact Council and recognized as one the Top 25 Women Leaders in Biotechnology and the Top 25 Healthcare Technology Leaders of New York, both by the Healthcare Technology Report.